NEUROCRINE BIOSCIENCES INC Quarterly Goodwill in USD from Q4 2021 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary: Neurocrine Biosciences Inc quarterly Goodwill history and growth rate from Q4 2021 to Q3 2024.
Neurocrine Biosciences Inc Goodwill for the quarter ending September 30, 2024 was $6.1M, a 10.9% increase year-over-year.

Goodwill, Quarterly (USD)

Goodwill, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$6.1M	+$600K	+10.9%	Sep 30, 2024	10-Q	2024-10-30
Q2 2024	$5.7M	$0	0%	Jun 30, 2024	10-Q	2024-08-01
Q1 2024	$5.7M	+$100K	+1.79%	Mar 31, 2024	10-Q	2024-05-01
Q4 2023	$5.8M	+$400K	+7.41%	Dec 31, 2023	10-Q	2024-10-30
Q3 2023	$5.5M			Sep 30, 2023	10-Q	2023-10-31
Q2 2023	$5.7M			Jun 30, 2023	10-Q	2023-08-01
Q1 2023	$5.6M			Mar 31, 2023	10-Q	2023-05-03
Q4 2022	$5.4M	+$5.4M		Dec 31, 2022	10-K	2024-02-09
Q4 2021	$0			Dec 31, 2021	10-K	2024-02-09

* An asterisk sign (*) next to the value indicates that the value is likely invalid.